Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
126 hedge funds and large institutions have $458M invested in Surmodics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 24 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 34
13% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 24
2% more funds holding
Funds holding: 124 → 126 (+2)
10.15% less ownership
Funds ownership: 92.92% → 82.77% (-10%)
18% less capital invested
Capital invested by funds: $557M → $458M (-$99.1M)
74% less call options, than puts
Call options by funds: $135K | Put options by funds: $527K
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$30.3M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$12.2M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$10M |
| 4 |
ECU
Eisler Capital (UK)
London,
United Kingdom
|
+$5.52M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
+$2.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$25.5M |
| 2 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$22.4M |
| 3 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$20.2M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$16.9M |
| 5 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
-$14.9M |
SRDX Hedge Fund Activity: Q3 2024 in Review
126 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2024, worth a combined $458M — down 18% from $557M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SRDX positions and 24 closed out — a net gain of 3 holders — while 39 added to existing stakes and 34 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $30.3M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $25.5M sold.
- 126 institutional investors held Surmodics (SRDX) as of Q3 2024, up from 124 in Q2 2024.
- Funds reported $458M of Surmodics stock for Q3 2024, down 18% quarter-over-quarter.
- 27 funds opened new Surmodics positions in Q3 2024 and 24 closed out, a net change of +3 holders.
- The largest Surmodics buyer in Q3 2024 was AllianceBernstein, an estimated $30.3M added.
- The largest Surmodics seller in Q3 2024 was Renaissance Technologies, an estimated $25.5M sold.
Based on aggregated 13F filings for Q3 2024.